AEGERA THERAPEUTICS

Pharmaceutical, medical and therapeutic products, namely small molecule pharmaceuticals, protein pharmaceuticals, antisense pharmaceuticals, cell therapy products, namely skin derived stem cells, for implantation into human tissues and organs, for use in the treatment of tumor shrinkage and death, cellular survival, apoptosis, regeneration and growth in the area of oncology, neurology, apoptosis, pain relief, tissue and organ regeneration and gene therapy

Product research and development, namely, development and expression of adenovirus vectors, screening for small molecules, determining role of genes with suspected neuronal involvement, chemistry optimization, determining routes to differentiate stem cells, in the fields of oncology, neurology, apoptosis, pain relief, tissue and organ regeneration and gene therapy